Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 14, 2009

iZumi Bio and Japanese Stem Cell Research Center to Collaborate

iZumi Bio and Japanese Stem Cell Research Center to Collaborate

iZumi and Kyoto University will research induced pluripotent stem cell

  • Izumi Bio and Kyoto University's Center for iPS Cell Research and Application will collaborate on research, development, and applications of induced pluripotent stem cell technology to advance drug discovery and cell-based therapies for patients. 

    The organizations' researchers will share some cell lines. iZumi and CiRA both offer the capability to take skin cells from a diseased patient with known genotypic and phenotypic information and reprogram them to behave similarly to human embryonic stem cells. The parties will conduct comparison and characterization studies independently but will share the best methods to produce appropriate cell lines for drug screening and development as well as those best suited for cell-based therapy.

    The focus for iZumi will be three neurological disorders: Parkinson's disease, amyotrophic lateral sclerosis, and spinal muscular atrophy.

    "Our approach is based on a paradigm shift that puts the patient at the forefront of the drug discovery process," says John P. Walker, iZumi CEO. "Using patient and disease-specific cells to develop assays and screening systems has the potential to change the way drug discovery has been conducted to date by shortening the time to clinic through the selection of drug candidates with a higher probability of success."


    Past Deals on Stem Cell Technology in R&D
    PerkinElmer to Continue Cord Blood Stem Cell Partnership with M.D. Anderson (Jan. 16, 2009)
    VistaGen and Capsant to Develop Stem Cell Technology for Drug R&D (Jan. 15, 2009)
    BioTime Licenses Human Embryonic Stem Cell Technology from WARF (Jan. 9, 2008)

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »